Table 2 Down-regulated GOIs after exposure of HSAEpC to various dilutions of cannabis oil extract for 24 h

ADRB2

Adrenergic receptor, beta 2

(0.40, 0.53)

AREG

Amphiregulin

(0.41, 0.54)

CCL5

Chemokine (C-C motif) ligand 5

(0.10, 0.36)

CLCA1

Chloride channel accessory 1

(0.03, 0.23)

(0.06, 0.26)

CMA1

Chymase 1, mast cell

(0.04, 0.10)

(0.20, 0.50)

EPX

Eosinophil peroxidase

(0.03, 0.04)

(0.11, 0.31)

FOXP3

Forkhead box P3

(0.12, 0.40)

IL3RA

Interleukin 3 receptor, alpha (low affinity)

(0.16, 0.52)

IL4R

Interleukin 4 receptor

(0.24, 0.28)

IL5

Interleukin 5 (colony-stimulating factor, eosinophil)

(0.06, 0.58)

IL13RA1

Interleukin 13 receptor, alpha 1

(0.29, 0.40)

IL33

Interleukin 33

(0.16, 0.21)

LTB4R

Leukotriene B4 receptor

(0.16, 0.23)

(0.39, 0.52)

MAF

V-maf musculoaponeurotic fibrosarcoma oncogene homolog (avian)

(0.20, 0.28)

(0.29, 0.37)

MMP9

Matrix metallopeptidase 9 (gelatinase B, 92 kDa gelatinase, 92 kDa type IV collagenase)

(0.22, 0.33)

PMCH

Pro-melanin-concentrating hormone

(0.17, 0.37)

(0.03, 0.14)

POSTN

Periostin, osteoblast specific factor

(0.16, 0.19)

RORC

RAR-related orphan receptor C

(0.00001, 0.36)

SATB1

SATB homeobox 1

(0.31, 0.65)

STAT5A

Signal transducer and activator of transcription 5A

(0.27, 0.38)

TNFSF4

Tumor necrosis factor (ligand) superfamily, member 4

(0.08, 0.31)